Upi.com
The U.S. Food and Drug Administration has approved Insmed’s daily bronchiectasis pill, brensocatib, which will be sold under the brand name Brinsupri…
Read More
First drug to treat bronchiectasis lung condition approved by FDA
Gaylene Catt
20:27
The U.S. Food and Drug Administration has approved Insmed’s daily bronchiectasis pill, brensocatib, which will be sold under the brand name Brinsupri…
